Records containing: Orthomyxoviridae Infections

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-04-24
  Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza
• CLINICAL_TRIALS study record update · 2023-08-03
  A Phase 2, Randomized, Study to Evaluate Safety and Immunogenicity of One or Two Heterologous Booster Vaccinations With an MF59-adjuvanted, Cell Culture-derived H5N6 Influenza Vaccine in Adults Primed With MF59-adjuvanted, Cell Culture-derived H5N1 Influenza Vaccine or Unprimed
• CLINICAL_TRIALS study record update · 2019-06-05
  Centralized IIS-Based Reminder Recall to Increase Influenza Vaccination Rates in New York State - Second Trial in New York State
• CLINICAL_TRIALS study record update · 2019-01-16
  Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (2018 Southern Hemisphere Season) Produced at Butantan Institute
• CLINICAL_TRIALS study record update · 2015-04-17
  Phase I, Open Label Study of a DNA Vaccine's Ability to Increase the Immune Response to the Trivalent Seasonal Influenza Vaccine in the Elderly
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2006-2007 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-17
  Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route)
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00545701
• CLINICAL_TRIALS study record update · 2014-01-14
  Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in European Children
• CLINICAL_TRIALS study record update · 2014-01-14
  Immunogenicity of the Inactivated Split-Virion Influenza Vaccine Administered by the Intradermal Route in Renal Transplant Subjects
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00491985
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00258934
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00457509
• CLINICAL_TRIALS study record update · 2014-01-14
  ClinicalTrials.gov study NCT00415129
• CLINICAL_TRIALS study record update · 2013-04-30
  A Stratified and Controlled Clinical Trial With Split-virion, Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Pregnant Women
• CLINICAL_TRIALS study record update · 2012-09-12
  A Double-blind, Randomized, Stratified and Controlled Clinical Trial With Split-virion, Adjuvanted and Non-adjuvanted Influenza A/H1N1 Vaccines in Healthy Adults, Elders, Adolescents and Children
• CLINICAL_TRIALS study record update · 2012-04-17
  Safety and Immunogenicity of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine in Healthy Adults
• CLINICAL_TRIALS study record update · 2010-04-01
  Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2008-2009 Formulation)
• CLINICAL_TRIALS study record update · 2010-01-26
  Phase1 An Observational Clinical Trial With an Influenza A (H1N1) 2009 Monovalent,Split-virion Vaccine in Healthy Adults, Aged 18-60 Years Phase2 Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients